Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts
1988

Flavone Acetic Acid and Colorectal Cancer

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): R. Giavazzi, A. Garofalo, G. Damia, S. Garattini, M. D'Incalci

Primary Institution: Mario Negri Institute for Pharmacological Research

Hypothesis

Does flavone acetic acid (FAA) have antitumor activity against human colorectal carcinoma xenografts?

Conclusion

Flavone acetic acid shows potential activity against human colorectal carcinoma, especially in reducing liver metastases.

Supporting Evidence

  • FAA significantly reduced liver tumor colonies in mice injected with HCC-M1410 cells.
  • Treatment with FAA increased the survival time of mice with HCC-P2988 tumors.
  • HCC-M1410 tumors were almost unresponsive to FAA when growing subcutaneously.

Takeaway

Flavone acetic acid might help fight certain types of colon cancer, especially when it spreads to the liver.

Methodology

The study involved injecting human colorectal carcinoma cells into nude mice and treating them with flavone acetic acid to evaluate tumor response.

Limitations

The study primarily focused on two specific colorectal carcinoma lines and may not represent all types of colorectal cancer.

Participant Demographics

Nude mice, specifically male NCr nu/nu mice aged 6-8 weeks.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication